X @Bloomberg

Moderna(US:MRNA) Bloomberg·2026-02-10 23:06

US regulators have refused to review Moderna’s novel mRNA flu vaccine, dealing a major blow to the company as it seeks more products beyond its Covid shot https://t.co/ei4gwXITGs ...